temozolomide has been researched along with wp1066 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, Z; Chen, L; Han, L; Jiang, T; Kang, C; Li, S; Liu, Y; Shi, Z; Wang, Y; Yan, W; Yang, P; You, G; Zhang, W | 1 |
1 other study(ies) available for temozolomide and wp1066
Article | Year |
---|---|
Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Disease-Free Survival; Drug Synergism; Female; Glioblastoma; Humans; Immunohistochemistry; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Retrospective Studies; Signal Transduction; STAT3 Transcription Factor; Temozolomide; Tyrphostins; Young Adult | 2011 |